Shares of Phoenix Asia Holdings Limited Ordinary Shares (NASDAQ:PHOE) are trading higher by 0.19% on Thursday as the company is entering into a stock acquisition agreement with ACEA Therapeutics, Inc. 



This move comes during a mixed market day, with the Nasdaq up 0.57% and the S&amp;P 500 gaining 0.14%, while the Dow Jones and Russell 2000 are slightly down.



On May 5, Phoenix Asia Holdings Limited has agreed to purchase 100% of the equity interests of ACEA Pharma, Inc. for a total value of $1 billion, which will be executed through the issuance of 100 million newly-issued ordinary shares at $10.00 each. 



This acquisition is expected to close by the end of the second quarter of 2026, subject to regulatory and stock exchange approvals.



The broader market is experiencing a mixed sentiment today, with technology stocks leading the gainers, which may be contributing to the positive movement in Phoenix Asia’s shares. Despite some sectors declining, the overall market’s slight upward trend appears to be supporting the stock’s performance.



Phoenix Asia operates its business through its indirectly wholly-owned operating subsidiary, focusing on substructure works, including site formation, ground investigation, and foundation works in Hong Kong. The company also provides additional construction services such as structural steelworks, which positions it as a key player in the local construction sector.



The recent acquisition of ACEA Pharma, Inc. is significant as it not only expands Phoenix Asia’s operational footprint but also enhances its capabilities in the pharmaceutical sector, potentially leading to new revenue streams and market opportunities.



<h2>Benzinga Edge Rankings</h2>



Below is the Benzinga Edge scorecard for Phoenix Asia Holdings, highlighting its strengths and weaknesses compared to the broader market:



<ul>
<li>– Momentum: Bullish (Score: 99.45) — Stock is outperforming the broader market.</li>



<li>– Value: Weak (Score: 0.64) — Trading at a steep premium relative to peers.</li>
</ul>



The Verdict: Phoenix Asia Holdings’ Benzinga Edge signal reveals a momentum-driven story, although the stock’s value ranking indicates it may be trading at a premium compared to its peers. Investors should consider the strong momentum alongside the potential risks associated with its valuation.



<h2>Price Action</h2>



PHOE Stock Price Activity: Phoenix Asia Hldgs shares were up 0.19% at $28.66 at the time of publication on Thursday, according to Benzinga Pro data.



Image via Shutterstock

ACRS

ATRX

PHOE

Phoenix Asia Holdings Limited shares rose 0.19% on Thursday following the announcement of a $1 billion stock acquisition of ACEA Pharma. This deal, involving 100 million newly-issued shares at $10 each, is expected to close by Q2 2026, pending regulatory approvals. The acquisition aims to expand Phoenix Asia's footprint in the pharmaceutical sector, potentially creating new revenue streams. Despite mixed market conditions, the stock's momentum remains bullish, although it trades at a premium compared to peers, indicating potential valuation risks for investors.

Why Is Phoenix Asia Stock Gaining Today?